CUE - Cue Biopharma, Inc.
12.455
-5.475 -43.958%
Share volume: 695,667
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$17.93
-5.48
-0.31%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | 05-12-2025 | 08-12-2025 | 11-12-2025 | 03-16-2026 | |
| Total revenue | 1.717 M | 2.658 M | 3.336 M | 421.000 K | 2.954 M | 2.149 M | 21.942 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.717 M | 2.658 M | 3.336 M | 421.000 K | 2.954 M | 2.149 M | 21.942 M | |
| 54.80% | 25.51% | -87.38% | 601.66% | -27.25% | 921.03% | |||
| Operating expenses | 14.385 M | 13.041 M | 12.248 M | 12.720 M | 11.589 M | 9.693 M | 19.985 M | |
| Selling general and admin | 4.186 M | 3.511 M | 2.867 M | 4.173 M | 3.679 M | 4.939 M | 3.453 M | |
| Research and development | 10.199 M | 9.530 M | 9.381 M | 8.547 M | 7.910 M | 4.754 M | 16.532 M | |
| Total expenses | 14.385 M | 13.041 M | 12.151 M | 12.720 M | 11.589 M | 9.744 M | 19.965 M | |
| -9.34% | -6.82% | 4.68% | -8.89% | -15.92% | 104.90% | |||
| Operating income | -12.668 M | -10.383 M | -8.815 M | -12.299 M | -8.635 M | -7.595 M | 1.977 M | |
| Ebit | -12.668 M | -10.383 M | -8.815 M | -12.299 M | -8.635 M | -7.595 M | 1.977 M | |
| Pretax income | -12.347 M | -10.171 M | -8.660 M | -12.257 M | -8.482 M | -7.448 M | 2.085 M | |
| -17.62% | -14.86% | 41.54% | -30.80% | -12.19% | -127.99% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -12.347 M | -10.171 M | -8.660 M | -12.257 M | -8.482 M | -7.448 M | 1.585 M | |
| 17.62% | 14.86% | -41.54% | 30.80% | 12.19% | 121.28% |